Your browser doesn't support javascript.
loading
Validation of Luminex immunological and competitive Luminex immunological assays for clinical immunogenicity assessment of a 14-valent recombinant human papillomavirus vaccine.
Zhang, Xiao; Meng, Dan; Li, Hong; Li, Xuefeng; Li, Jing; Hu, Ping; Zhao, Lu; Wang, Rui; Zhao, Chaonan; Luo, Chunxia; Gu, Weihua; Gai, Wenlin; Wang, Yang; Xie, Liangzhi.
Afiliación
  • Zhang X; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Meng D; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Li H; Shanghai Xihua Scientific Co., Ltd., Shanghai, China.
  • Li X; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Li J; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Hu P; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Zhao L; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Wang R; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Zhao C; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Luo C; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Gu W; Shanghai Xihua Scientific Co., Ltd., Shanghai, China.
  • Gai W; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Wang Y; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
  • Xie L; Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., Beijing, China.
J Med Virol ; 95(8): e29050, 2023 08.
Article en En | MEDLINE | ID: mdl-37635425

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones por Papillomavirus / Vacunas contra Papillomavirus Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: J Med Virol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos